Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Sorin completes the first US clinical implant of Ovatio CRT

Sorin : 22 October, 2007  (New Product)
ELA Medical, a Sorin Group company, has completed the first US implant in the investigational trial of the Ovatio CRT, Cardiac Resynchronization Therapy Defibrillator, Model 6750.
The first clinical Implant of Ovatio CRT-D, the smallest biventricular ICD currently available outside the USA at 30cc, was successfully performed by Dr Eli S Gang, clinical professor of medicine, David Geffen School of Medicine, UCLA.

The Implant occurred at Brotman Medical Center, Culver City, California, USA.

Cardiac resynchronization ICD therapy for heart failure patients at risk of sudden cardiac death (SCD) has become a standard-of-care treatment. Cardiac Resynchronization Therapy (CRT) has been shown, using earlier devices, to improve quality of life, increase exercise capacity, and reduce hospitalisations and mortality.

In patients with poor ventricular function, there is a high incidence of slow ventricular tachycardias (VT) and these arrhythmias have significant clinical effects. A recent publication indicated that not maintaining CRT during exercise might not allow the patient to experience prolonged, and eventually beneficial, physical activity. Ovatio CRT's BTO feature (Brady-Tachy Overlap) is designed to ‘Unlock Pacing and Detection’ to ensure delivery of resynchronization therapy during exercise.

“I like the fact that with the smallest CRT-D in the world I can pace my patients during exercise as well as detect and treat slower rate VTs without programming constraints”, stated Dr Eli Gang.

Ovatio CRT also includes P And R Arrhythmia Detection (PARAD /PARAD+) for maximum specificity of ventricular tachycardia.

Studies using earlier ELA ICDs, demonstrated that PARAD+ has a superior specificity in discriminating atrial from ventricular arrhythmias, without a reduction in sensitivity. For heart failure patients, not only is it vital that life saving therapies be delivered when necessary, but also that unnecessary and painful shocks be avoided to improve quality of life.

'The Ovatio CRT-D reflects the Sorin Group's commitment and dedication to the development of innovative, state-of-the-art cardiac rhythm devices that improve patients' longevity and quality of life”, said Richard Ames, senior vice president, US Cardiac Rhythm Management (CRM).
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   Â© 2012
Netgains Logo